Refractory B-cell chronic lymphocytic leukemia

Also known as: B-cell chronic lymphocytic leukemia/prolymphocytic leukemia/small lymphocytic lymphoma refractory / B-cell chronic lymphocytic leukaemia/prolymphocytic leukaemia/small lymphocytic lymphoma refractory / B-cell small lymphocytic lymphoma refractory / Small lymphocyte B lymphoma (Lukes-Collins Classification) refractory

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB01073	Fludarabine	A purine analog antimetabolite that inhibits DNA synthesis.

Drug	Drug Name	Target	Type
DB01073	Fludarabine	DNA polymerase alpha catalytic subunit	target
DB01073	Fludarabine	Ribonucleoside-diphosphate reductase large subunit	target
DB01073	Fludarabine	Equilibrative nucleoside transporter 1	transporter
DB01073	Fludarabine	DNA	target
DB01073	Fludarabine	Deoxycytidine kinase	target
DB01073	Fludarabine	Solute carrier family 28 member 3	transporter

Drug	Drug Name	Phase	Status	Count